The Valley Desk

Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University Hospital, with Jefferson Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Neoplasm Recurrence, Local; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Radiation-Sensitizing Agents; Neoplasm Staging; Combined Modality Therapy; Cystectomy; Adult; Aged; Aged, 80 and over; Middle Aged
PubMed ID
39226514
PubMed Central ID
PMC11960038
Added to directory
Source checked

Report a correction or request removal